{'fraction_non_alphanumeric': 0.04499151103565365, 'fraction_numerical': 0.0432937181663837, 'mean_word_length': 4.383561643835616, 'pattern_counts': {'":': 0, '<': 2, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
DS27: Outcomes in wound healing after lower leg skin surgery

definitive treatment time (TWWt; target 62 days). The secondary outcome measures included SCC severity (macroscopic diameter, tumour thickness, perineural or lymphovascular invasion, tumour stage) and MM severity (Breslow thickness, tumour stage). In total, 77 cases were analysed from 2019 and 78 from 2020; differences were explored using the N – 1 v-test. The number of referrals meeting the target TWWa (75% vs. 44%; P < 0 001), DTT (56% vs. 40%; P < 0 05) and TWWt (63% vs. 35%; P = 0 02) was higher in all categories in our 2019 cohort. We also saw a tendency for tumours associated with a worse prognosis during the pandemic, e.g. a mean MM Breslow thickness of 1 98 mm vs. 1 36 mm. Our results reflect the detrimental impact of the pandemic on our ability to deliver timely cancer care. Our data were limited by the small number of patients and provide a preliminary insight into the impact of the COVID-19 pandemic on skin cancer services. The impact on tumour severity, recurrence rates, quality of life and mental health of our patients requires further analysis in order to plan for future health crises.